ZSAN - Zosano Pharma Corporation (ZSAN) CEO John Walker on Q2 2018 Results - Earnings Call Transcript
Zosano Pharma Corporation (ZSAN)
Q2 2018 Earnings Conference Call
August 09, 2018 4:30 PM ET
Executives
Carol Lizak - Senior Director and Corporate Controller
John Walker - Chief Executive Officer
Donald Kellerman - Vice President of Clinical Development & Medical Affairs
Peter Smith - Senior Director of Medical Affairs Group
Analysts
Robert Hazlett - BTIG
Presentation
Operator
Good afternoon and thank you all for joining Zosano's Second Quarter Financial Results and Operational Update Conference Call. At this time, all participants are in a listen-only mode. Following management's remarks, we will hold a brief question-and-answer session